Clinical Trial

Brain Connectivity in Treatment Resistant Depression

Study Description

Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression

Study TRD subjects' resistance to at least 2 different antidepressants, we hypothesize that because of their significant depression and treatment resistant status they are most likely to exhibit BSMN pathway abnormalities.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Monoamine Oxidase Inhibitor (MAOI)

Monoamine Oxidase Inhibitor

Additional Information

Official Study Title

Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression

Clinical Trial ID

NCT03109717

ParticipAid ID

mbk0Ed